Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Lowenstein

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Human Gene Therapy|May 8, 2001
Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectorsC E Thomas, G Schiedner, S Kochanek, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2002
Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexityA Grande-Pérez, S Sierra, M G Castro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brainC E Thomas, D Birkett, I Anozie, et al.
European Journal of Biochemistry|February 1, 1993
Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humansS Sharp, E V Barker, M W Coughtrie, et al.
Endocrinology|January 6, 2001
Long-term transgene expression within the anterior pituitary gland in situ: impact on circulating hormone levels, cellular and antibody-mediated immune responsesT D Southgate, D Stone, J C Williams, et al.
Brain Research Bulletin|December 6, 2005
Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor ageE M Torres, C Monville, P R Lowenstein, et al.
Gene Therapy|January 1, 1994
Adenovirus vectors to transfer genes into neurones: implications for gene therapy of neurological disordersD Bain, G W Wilkinson, C M Preston, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Cell type-specific expression from viral promoters within replication-deficient adenovirus recombinants in primary neocortical culturesP R Lowenstein, D Bain, A F Shering, et al.
Gene Therapy|January 11, 2000
Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cellsO Brown, R L Cowen, C M Preston, et al.
Brain Research. Molecular Brain Research|June 14, 2005
In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine systemE M Torres, C Monville, P R Lowenstein, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Human Gene Therapy|May 8, 2001
Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectorsC E Thomas, G Schiedner, S Kochanek, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2002
Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexityA Grande-Pérez, S Sierra, M G Castro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brainC E Thomas, D Birkett, I Anozie, et al.
European Journal of Biochemistry|February 1, 1993
Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humansS Sharp, E V Barker, M W Coughtrie, et al.
Endocrinology|January 6, 2001
Long-term transgene expression within the anterior pituitary gland in situ: impact on circulating hormone levels, cellular and antibody-mediated immune responsesT D Southgate, D Stone, J C Williams, et al.
Brain Research Bulletin|December 6, 2005
Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor ageE M Torres, C Monville, P R Lowenstein, et al.
Gene Therapy|January 1, 1994
Adenovirus vectors to transfer genes into neurones: implications for gene therapy of neurological disordersD Bain, G W Wilkinson, C M Preston, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Cell type-specific expression from viral promoters within replication-deficient adenovirus recombinants in primary neocortical culturesP R Lowenstein, D Bain, A F Shering, et al.
Gene Therapy|January 11, 2000
Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cellsO Brown, R L Cowen, C M Preston, et al.
Brain Research. Molecular Brain Research|June 14, 2005
In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine systemE M Torres, C Monville, P R Lowenstein, et al.
Pageof 13